Tuesday
SESSION 8: CONTROVERSIES AND NEW DEVELOPMENTS IN THE MANAGEMENT OF UNCOMPLICATED TBADs
Location: Grand Ballroom West, 3rd Floor
Moderators:Rodney A. White, MD / Frank J. Veith, MD  
SESSION 8 SCHEDULE
4:48 PM - 4:53 PM New Developments In The Endovascular Treatment Of Uncomplicated TBAD Patients: The FLIRT Concept: What Has Changed: TEVAR Is Indicated In Most At 2-8 Weeks After Onset: Who Are They And What Else Is Needed
  Presenter(s):Christoph A. Nienaber, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:54 PM - 4:59 PM Trends In US National Treatment For Asymptomatic Uncomplicated TBADs: From The National Inpatient Sample Through 2015
  Presenter(s):Raghuveer Vallabhaneni, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:00 PM - 5:05 PM When Should Acute Uncomplicated TBADs Be Treated By TEVAR: How Can Imaging Help
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:06 PM - 5:11 PM Outcomes Of Endovascular Repair Of Multi-Channeled Aortic Dissection With And Without Full True Lumen Collapse
  Presenter(s):Weiguo Fu, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:12 PM - 5:17 PM DEBATE: The Case For Treating All Uncomplicated Acute TBAD Patients With TEVAR
  Presenter(s):Ross Milner, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:18 PM - 5:23 PM DEBATE: The Case Against TEVAR For All Uncomplicated Acute TBAD Patients And For Good Medical Treatment Alone For Most: What Constitutes Good Medical Treatment
  Presenter(s):Ali Azizzadeh, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:24 PM - 5:29 PM Patient Compliance With Good Medical Therapy For TBADs Is Poor: How Can This Be Improved And What Is Its Impact On The Debate Over Optimal Treatment For These Patients
  Presenter(s):Colin D. Bicknell, MD FRCS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:30 PM - 5:35 PM Another Controversial Opinion: Why TEVAR Should Be Performed On All Acute TBAD Patients
  Presenter(s):Mark Conrad, MD, MMSc  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:36 PM - 5:41 PM A Different Controversial Opinion: Not So: Why TEVAR Should Only Be Performed Selectively On Patients With Uncomplicated Acute TBADs
  Presenter(s):Michel Makaroun, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:42 PM - 5:47 PM DEBATE: Why A Randomized Controlled Trial (RCT) Of TEVAR And Medical Treatment vs. Medical Treatment Alone Is Needed For Acute Uncomplicated TBADs: Such A Trial (INTACT-AD) Has Been Designed With The Following Features . . .
  Presenter(s):Firas F. Mussa, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:48 PM - 5:53 PM DEBATE: We Donít Need Such A RCT: Data From The SVS Registry And Other Sources Will Suffice
  Presenter(s):Richard P. Cambria, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:54 PM - 6:02 PM Panel Discussion
End of Program A
END OF SESSION 8
previous next